AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 145 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $79,104 | -48.7% | 18,745 | -63.1% | 0.00% | – |
| Q2 2023 | $154,250 | +97.3% | 50,805 | -9.7% | 0.00% | – |
| Q1 2023 | $78,186 | -29.6% | 56,250 | +1.5% | 0.00% | – |
| Q4 2022 | $111,000 | -5.9% | 55,399 | -5.3% | 0.00% | – |
| Q3 2022 | $118,000 | -38.5% | 58,490 | +0.0% | 0.00% | – |
| Q2 2022 | $192,000 | +51.2% | 58,487 | -0.0% | 0.00% | – |
| Q1 2022 | $127,000 | -55.0% | 58,489 | +0.2% | 0.00% | -100.0% |
| Q4 2021 | $282,000 | -8.7% | 58,355 | +3.5% | 0.00% | 0.0% |
| Q3 2021 | $309,000 | +9.2% | 56,356 | +4.4% | 0.00% | 0.0% |
| Q2 2021 | $283,000 | +1.1% | 53,994 | +27.5% | 0.00% | 0.0% |
| Q1 2021 | $280,000 | +67.7% | 42,357 | +16.0% | 0.00% | – |
| Q4 2020 | $167,000 | -25.1% | 36,521 | -24.3% | 0.00% | -100.0% |
| Q3 2020 | $223,000 | -2.2% | 48,223 | +0.3% | 0.00% | 0.0% |
| Q2 2020 | $228,000 | +68.9% | 48,082 | +13.4% | 0.00% | 0.0% |
| Q1 2020 | $135,000 | – | 42,384 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $103,087,000 | 5.89% |
| Eversept Partners, LP | 6,440,572 | $30,850,340 | 1.97% |
| TPG GP A, LLC | 16,213,367 | $77,662,000 | 0.78% |
| Signature Wealth Management Partners, LLC | 87,666 | $420,000 | 0.36% |
| Hedges Asset Management LLC | 75,000 | $359,000 | 0.28% |
| Hillsdale Investment Management Inc. | 869,916 | $4,167,000 | 0.28% |
| Tranquilli Financial Advisor LLC | 71,414 | $342,000 | 0.24% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 180,000 | $862,000 | 0.19% |
| GLOBEFLEX CAPITAL L P | 297,414 | $1,424,000 | 0.15% |
| XTX Topco Ltd | 23,742 | $114,000 | 0.06% |